1Lee JS, Shin JH, Hwang JH, Baek JE, Choi BS (2014) Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease. Saf Health Work 5: 91-96.

2Ben Moussa S, Sfaxi I, Tabka Z, Ben Saad H, Rouatbi S (2014) Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study. Libyan J Med 9: 23873.

3Ford ES, Li C, Cunningham TJ, Croft JB (2014) Associations between antioxidants and all-cause mortality among US adults with obstructive lung function. Br J Nutr 112: 1662-1673.

4Domej W, Oettl K, Renner W (2014) Oxidative stress and free radicals in COPD - implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis 9: 1207-1224.

5Joppa P, Petrásová D, Stancák B, Dorková Z, Tkácová R (2007) Oxidative stress in patients with COPD and pulmonary hypertension. Wien Klin Wochenschr 119: 428-434.

6Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, et al. (2013) Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 41: 1292-1301.

7Held M1, Jany BH (2013) Pulmonary hypertension in COPD. Respir Care 58: e86-91.

8Reis GS, Augusto VS, Silveira AP, Jordão AA Jr, et al. (2013) Oxidative-stress biomarkers in patients with pulmonary hypertension. Pulm Circ 3: 856-861.

9Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, et al. (2004) Oxidative stress in severe pulmonary hypertension. Am J Respir Crit Care Med 169: 764-769.

10West JB (2013) GOLD Executive Summary. Am J Respir Crit Care Med 188: 1366-1367.

11Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. (2009) ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 30: 2493-2537.

12Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.

13Beutler E, Gelbart T (1985) Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 105: 581-584.

14Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. (2004) Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43: 40S-47S.

15Cracowski JL, Cracowski C, Bessard G, Pepin JL, Bessard J, Schwebel C, et al. (2001) Increased lipid peroxidation in patients with pulmonary hypertension. Am J Respir Crit Care Med 164: 1038-1042.

16Liu J, Thomas PS (2005) Exhaled breath condensate as a method of sampling airway nitric oxide and other markers of inflammation. Med Sci Monit 11: M53-M62.

17Ochs-Balcom HM, Grant BJ, Muti P, Sempos CT, Freudenheim JL, Browne RW, et al. (2006) Anti-oxidants, oxidative stress and pulmonary function in individuals diagnosed with asthma or COPD. Eur J Clin Nutr 60: 991-999.

18Nobre C, Mesquita D, Thomas B (2013) Echocardiography in pulmonary hypertension. Chest 144: 1426.

19Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT (2014) CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest 145: 824-832.

20Gutteridge JMC (1986) Aspects to consider when detecting and measuring lipid peroxidation. Free Radic Res Commun 1: 173-184.